Obexelimab for the Treatment of IgG4-Related Disease

Emanuel Della-Torre

Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan

Matthew C. Baker

Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Palo Alto, CA

Wen Zhang

Cory A. Perugino

Division of Rheumatology, Inflammation, and Immunity, Mass General Brigham, Boston

Guy Katz

Division of Rheumatology, Inflammation, and Immunity, Mass General Brigham, Boston

Yoshiya Tanaka

Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health, Kitakyushu, Japan

Arezou Khosroshahi

Division of Rheumatology, Emory University School of Medicine, Atlanta

Alexander Kleger

Nicolas Schleinitz

Department of Internal Medicine, Aix-Marseille Université, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Timone, Marseille, France

Fernando Martinez-Valle

Vall d’Hebron University Hospital, Barcelona

Hendrik Schulze-Koops

Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany

Shingo Nakayamada

First Department of Internal Medicine and Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health, Kitakyushu, Japan

Vinciane Rebours

Pancreatology and Digestive Oncology Department, Beaujon Hospital, Université Paris Cité, Clichy, France

Kazuichi Okazaki

Kansai Medical University Kori Hospital, Osaka, Japan

Lingli Dong

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Mollie Carruthers

Arthritis Research Canada, Vancouver, BC

Luke Y.C. Chen

Dalhousie Medical School, Halifax, NS, Canada

Luca Frulloni

Pancreas Center, University of Verona, Department of Medicine, Verona, Italy

Alireza Meysami

Henry Ford Health, Detroit

Hiroki Takahashi

Mitsuhiro Kawano

Kanazawa Medical University, Kahoku-gun, Japan

Yanying Liu

Beijing Friendship Hospital, Capital Medical University, Beijing

Takako Saeki

Nagaoka Red Cross Hospital, Nagaoka, Japan

Mikael Ebbo

Department of Internal Medicine, Aix-Marseille Université, Assistance Publique–Hôpitaux de Marseille, Hôpital de la Timone, Marseille, France

Tobias Alexander

Department of Rheumatology and Clinical Immunology, Charité–Universitätsmedizin Berlin, Berlin

Andrés González García

Department of Internal Medicine, Hospital Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid

Omer Karadag

Division of Rheumatology, Department of Internal Medicine, Vasculitis Research Center, Hacettepe University, Ankara, Turkey

Maria Maślińska

Department of Rheumatology, National Institute of Geriatrics, Rheumatology, and Rehabilitation, Warsaw, Poland

Shauna M. Quinn

Zenas BioPharma, Waltham, MA

Allen Poma

Zenas BioPharma, Waltham, MA

Audrey Wells

Zenas BioPharma, Waltham, MA

Thomas J. Greene

Zenas BioPharma, Waltham, MA

John H. Stone

Division of Rheumatology, Inflammation, and Immunology, Massachusetts General Hospital, Boston

Emma L. Culver